Earnings
RNAZ
3.490
-13.18%
-0.530
Currencies: USD
Items
Cash and Cash Equivalents
Short-term Investments
Short-term Securities
Accounts Receivable
Notes Receivable
Interest Receivable
Other Receivables
Prepayments
Inventories
Holding Assets for Sale
Unamortized Expenditures
Other Current Assets
Total Current Assets
Fixed Assets Net
Long-term Receivables
Long-term Investments
Deferred Tax Asset
Goodwill
Intangible Assets
Long-term Deferred Expenses
Other Non-current Assets
Total Non-current Assets
Total Assets
Short/Current Long Term Debt
Accounts Payable
Notes Payable
Taxes and Dues Payable
Salary Payable
Financing Expenses Payable
Other Payable
Advance Receipt
Accrued Expenses
Deferred Income
Holding Liabilities For Sale
Financial Derivative Liabilities
Other Current Liabilities
Total Current Liabilities
Long-term Debt
Long-term Payables
Long-term Deferred Income
Long-term Deferred Tax Liabilities
Other Non-current Liabilities
Total Non-current Liabilities
Total Liabilities
Common Stocks
Additional Paid-in Capital
Retained Earnings
Treasury Shares
Other Equity Instruments
Minority Interest
Equities Attributable to Parent Company
Total Equities
Total Liabilities and Equities
FY 2021-12-31
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
1.06M
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
4.46M
--
--
--
--
--
--
--
--
--
FY 2020-12-31
828.02K
--
--
--
--
--
0.00
--
--
--
3200.00
--
831.22K
--
--
--
--
--
--
--
224.15K
224.15K
1.06M
--
--
0.00
--
--
--
369.18K
--
--
--
--
--
35.69K
404.86K
2.09M
--
--
--
1.97M
4.06M
4.46M
460.00
53.19K
-3.46M
--
--
--
-3.41M
-3.41M
1.06M
FY 2019-12-31
204.47K
--
--
--
--
--
0.00
--
--
--
0.00
--
204.47K
--
--
--
--
--
--
--
0.00
0.00
204.47K
--
--
0.00
--
--
--
27.26K
--
--
--
--
--
35.69K
62.94K
927.81K
--
--
--
323.50K
1.25M
1.31M
460.00
7740.00
-1.12M
--
--
--
-1.11M
-1.11M
204.47K
FY 2018-12-31
212.98K
--
--
--
--
--
0.00
--
--
--
1670.00
--
214.65K
--
--
--
--
--
--
--
--
0.00
214.65K
--
--
0.00
--
--
--
82.00K
--
--
--
--
--
35.69K
117.68K
436.22K
--
--
--
164.72K
600.93K
718.61K
760.00
6050.00
-510.78K
--
--
--
-503.97K
-503.97K
214.65K

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out RNAZ latest quarterly and annual financial reports. There are also historical financial reports for you to reference. You can analyze Transcode Therapeutics, Inc. recent business situations by check its income statements, balance sheets, cash flow statements and other tables. This information may help you make smarter investment decisions.